Clinical Trial Operations Intern

About the role

As a Clinical Trial Operations Intern, you will gain hands-on exposure to clinical trial planning, operations, and delivery. You will contribute to projects that strengthen Genmab’s clinical trial execution capabilities through process improvement, data-driven insights, and operational excellence. Working cross-functionally with experts in Clinical Operations, Vendor Oversight and Standards, Clinical Data, Integration & Reporting, and Trial Planning, you’ll apply both scientific and technical skills to enhance clinical trial efficiency and execution; documenting clinical operation practices that are consistent, scalable, and inspection ready. This role is ideal for individuals pursuing advanced studies in life sciences, biomedical engineering, or related fields, with a strong interest in clinical research, regulatory systems, and project management.

At Genmab, interns don’t just learn about the work — they help move it forward. Our internship program provides meaningful, hands-on experience through real projects that directly support our teams, business priorities, and mission to transform the lives of people with cancer and other serious diseases. From day one, interns are welcomed as part of the team and given opportunities to contribute, collaborate, and make an impact. Along the way, you’ll learn from talented colleagues and senior leaders, build new skills, expand your professional network, and gain exposure to the innovative work happening across Genmab.

Responsibilities

• Process optimization and quality documentation — Contribute to designing compliant processes and assist in ensuring high-quality documentation aligned with regulatory standards.
• Business and clinical trial operations — Support enhancements and/or building new operational tools leveraging AI, PowerBI or other software, including requirements gathering, testing, and process documentation.
• Inspection readiness and trial documentation — Develop a practical readiness toolkit by reviewing trial documentation, identifying common gaps, and creating checklists or dashboards that support consistent, inspection-ready execution.
• Trial performance metrics and insights — Analyze operational data to identify trends, bottlenecks, and improvement opportunities, and develop clear visualizations or summaries for study teams and leadership.
• Knowledge management and digital enablement — Organize clinical operations guidance and lessons learned into accessible resources and explore responsible uses of automation or AI to improve information retrieval and team collaboration.

Requirements

• Currently pursuing a Bachelor’s degree (Junior or Senior standing) or Master’s degree in Life Sciences, Biomedical Engineering, Drug Discovery and Development, or a related discipline.
• Strong analytical and organizational skills with proficiency in Microsoft Office Suite (Excel, Word, PowerPoint, SharePoint) and comfort with AI and/or PowerBI to solve complex problems.
• Demonstrated ability to manage data, documentation, or process improvement projects.
• Excellent communication, teamwork, and problem-solving skills.

Preferred qualifications

• Experience using or classwork in Lean, Six Sigma and/or Project Management practices.
• Knowledge or experience in GxP practices or ICH guidelines.
• Experience with Planisware, Veeva Vault, or other trial management systems.
• Background in clinical operations, drug development, or medical technology research.

Schedule and location

Internships will take place over 10 weeks from June – August 2027. This role will be based in Princeton, NJ and operate on a required hybrid schedule — 3 days in the office and 2 days remote per week. This role is not eligible for work visa sponsorship at the time of the application or in the future.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines. Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific.